Simulations Plus (SLP) risk factors
Item 1A of every Simulations Plus, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors42 risks4 new4 dropped12 reworded
The company added explicit risk disclosures regarding artificial intelligence utilization, evolving data privacy laws, and U.S. government grant interruptions under DOGE. Terminology shifted consistently from customers to clients across multiple existing risk factors.
Filed Dec 01, 2025 - FY2024 10-K risk factors42 risks
Simulations Plus faces key risks from pharmaceutical R&D spending trends and drug development regulation. Software defects, hosting failures, and integration issues from the Pro-ficiency and Immunetrics acquisitions threaten results. Heavy reliance on fixed-price contracts and international markets introduces cost overruns and currency exposure.
Filed Oct 30, 2024